AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-887-90
Published September 12, 2018 · Recall initiated: July 18, 2018
Summary
FDA records drug Class II recall D-1175-2018, published September 12, 2018 and initiated July 18, 2018. Recalling firm: Avkare Incorporated; Status: Terminated; Reported quantity: 19109 bottles; Lot: Lots: 17325 Exp. 09/2018; 17856 Exp. 09/2018; 18396 Exp. 09/2018; 18702 Exp. 02/2019; 19020 Exp. 02/2019; 19222 Exp. 02/2019; 20030 Exp. 04/2019; 20381 Exp. 04/2019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Avkare Incorporated
- Distributor
- Nationwide
- Lot
- Lots: 17325 Exp. 09/2018; 17856 Exp. 09/2018; 18396 Exp. 09/2018; 18702 Exp. 02/2019; 19020 Exp. 02/2019; 19222 Exp. 02/2019; 20030 Exp. 04/2019; 20381 Exp. 04/2019
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for:September 12, 2018
- FDAAvKARE Valsartan and Hydrochlorothiazide 160 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactured for:September 12, 2018
- FDAEthosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For VersaPharm Incorporated,September 12, 2018
- FDAVirt-Nate Tablets, Number of units per package: 100 Tablets Package Type: 100 Tablets/BottleSeptember 12, 2018
- FDAGE Carestation 620/650/650c, A1 and A2 (non-US distribution) anesthesia systemsSeptember 5, 2018
- FDAP.F.C. SIGMA Revision Knee System Distal Augment, Model Number 960830September 5, 2018
Questions about this recall
Was AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tablets, 90-count bottle, Rx Only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 42291-887-90 recalled?
Yes. FDA published recall D-1175-2018 on September 12, 2018. Reported hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter